- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04108143
Use of MonitorMe in COPD
Use of MonitorMe in COPD: a Mixed-methods Feasibility Study
MonitorMe is a telephone device intended for the non-critical monitoring of vital signs in a domestic environment with the ability to automatically transmit data to a remote location via basic telephone connectivity.
MonitorMe's low-cost, call automation and simple to use technology (i.e. based on the principles of an ordinary plug-in telephone) make it appropriate for a wide number of care pathways. It eliminates the need for a modem or broadband and avoids the challenges of less reliable smart phone technology. Typical use scenarios include remote monitoring of individual or multiple chronic disease states such as COPD to improve patient outcomes including prevention of emergency admissions.
There is growing interest in the use of home telemonitoring in COPD in order to facilitate the management of the increasing numbers of patients and pressures on the NHS. Despite the positive effects of telemonitoring in conditions such as heart failure, benefits remain unproven in COPD and further work is required before wide-scale use.
Furthermore, until now the evaluation of telecare and telehealth developments has focused mainly on effectiveness and efficiency, whereas their social, and ethical implications in particular, have not been explored in depth. We will also explore ethical issues related to the use of telehealth systems, from both the patients' and the healthcare professionals' perspective.
The current feasibility study is designed to assess the acceptability, usability and validity of MonitorMe within one of its intended purposes i.e. remote monitoring of individual or multiple chronic disease states such as COPD.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Lincoln, Det Forenede Kongerige, LN6 7TS
- University of Lincoln
-
Lincoln, Det Forenede Kongerige
- Lincolnshire Community Health Services NHS Trust
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Patients
- Adults diagnosed with any severity of COPD (according to British Thoracic Society criteria, i.e. >10 pack year smoking history and post bronchodilator spirometry FEV1/FVC ratio <0.70 and FEV<80%)
- Listed on referral lists or COPD registers within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
Health care professionals
- Involved in implementing the device within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
- Provide informed consent to participate in an interview
Exclusion Criteria:
Patients
- Inability or unwillingness to sign informed consent
- No active telephone line in home
- COPD exacerbation within the previous 6 weeks.
- Mental health, cognitive or neurological conditions that would make study participation inappropriate
- Life expectancy < 6 months
- Implanted pacemaker
- Hearing or visual ailments that would preclude the use of the MonitorMe device
- Inability to use both hands (i.e. hold handset in one hand and use keypad with the other at same time)
- Inability to understand verbal English
Health care professionals
- Not involved in implementing the device within Lincolnshire Community Health Services NHS Trust or NHS South West Lincolnshire CCG
- Unable/unwilling informed consent to participate in an interview
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Intervention
MonitorMe device
|
MonitorMe replaces the users existing telephone and for the majority of time is used as their ordinary telephone.
At a known and set time of day for 4 weeks, participants will receive an automated MonitorMe telephone call.
The participant answers a health and well-being automated script by pressing key pad numbers.
At the same time vital signs data are collected.
The responses and vital signs data, together with confidence values are then transmitted via telephone lines to an electronic patient record.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Oxygen Saturation
Tidsramme: Day 0 to 28
|
Agreement between measurements made by MonitorMe and healthcare professionals
|
Day 0 to 28
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Temperature
Tidsramme: Day 0 to 28
|
Agreement between measurements made by MonitorMe and healthcare professionals
|
Day 0 to 28
|
Heart rate/pulse rate
Tidsramme: Day 0 to 28
|
Agreement between measurements made by MonitorMe and healthcare professionals
|
Day 0 to 28
|
Adverse event rate
Tidsramme: Day 0 to 28
|
Number of reported adverse events during study period
|
Day 0 to 28
|
Patient compliance
Tidsramme: Day 0 to 28
|
Number of MonitorMe automated calls completed during observation period
|
Day 0 to 28
|
Usability
Tidsramme: Day 0 to 28
|
Number of unsuccessful data transmissions or missing data (confidence values of MonitorMe)
|
Day 0 to 28
|
Acceptance/experience of MonitorMe for patients
Tidsramme: Day 28 to 84
|
Semi-structured interviews
|
Day 28 to 84
|
Acceptance/experience of MonitorMe for health care professionals
Tidsramme: Day 28 to 84
|
Semi-structured interviews
|
Day 28 to 84
|
Self-reported disease specific assessment of quality of life
Tidsramme: Day 0 and Day 28
|
Chronic Respiratory Questionnaire
|
Day 0 and Day 28
|
Recruitment rates
Tidsramme: 1 year
|
Time taken to achieve planned sample size
|
1 year
|
Consent rate
Tidsramme: 1 year
|
Number of eligible patients willing to consent to take part in the study
|
1 year
|
Retention rate
Tidsramme: Day 0 to 28
|
Number of patients who complete the study
|
Day 0 to 28
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Aloysius N Siriwardena, MBBS, PhD, University of Lincoln
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 181003
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .